Tsontcho Ianchulev

5.7k total citations · 3 hit papers
52 papers, 4.3k citations indexed

About

Tsontcho Ianchulev is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Tsontcho Ianchulev has authored 52 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Ophthalmology, 39 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Epidemiology. Recurrent topics in Tsontcho Ianchulev's work include Retinal Diseases and Treatments (27 papers), Glaucoma and retinal disorders (26 papers) and Retinal Imaging and Analysis (16 papers). Tsontcho Ianchulev is often cited by papers focused on Retinal Diseases and Treatments (27 papers), Glaucoma and retinal disorders (26 papers) and Retinal Imaging and Analysis (16 papers). Tsontcho Ianchulev collaborates with scholars based in United States, Canada and Spain. Tsontcho Ianchulev's co-authors include David M. Brown, Jeffrey S. Heier, Judy P. Sy, Mark Michels, Peter K. Kaiser, Sonia H. Yoo, Jayakrishna Ambati, Balamurali K. Ambati, Anthony P. Adamis and Naveed Shams and has published in prestigious journals such as JAMA, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Tsontcho Ianchulev

50 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

2008 1.1k citations David M. Brown, Mark Michels et al. Ophthalmology profile →
Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies

2003 748 citations Jayakrishna Ambati, Balamurali K. Ambati et al. Survey of Ophthalmology profile →
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

2008 693 citations Carl D. Regillo, David M. Brown et al. American Journal of Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsontcho Ianchulev United States	24	4.0k	3.1k	680	354	156	52	4.3k
Dennis M. Marcus United States	34	4.9k 1.2×	3.8k 1.2×	888 1.3×	196 0.6×	153 1.0×	105	5.8k
José Garcia-Arumı́ Spain	39	3.9k 1.0×	2.8k 0.9×	881 1.3×	260 0.7×	85 0.5×	171	4.6k
Daniel Kook Germany	27	2.1k 0.5×	1.8k 0.6×	346 0.5×	430 1.2×	320 2.1×	72	2.6k
Christian Simader Austria	37	6.4k 1.6×	5.3k 1.7×	755 1.1×	383 1.1×	91 0.6×	100	6.7k
Adam R. Glassman United States	49	8.6k 2.2×	7.3k 2.4×	820 1.2×	304 0.9×	136 0.9×	95	9.0k
Michael Ulbig Germany	33	3.5k 0.9×	3.0k 1.0×	660 1.0×	155 0.4×	85 0.5×	121	4.0k
Roman G. Rubio United States	25	6.6k 1.7×	4.8k 1.6×	731 1.1×	162 0.5×	84 0.5×	58	7.1k
Yit C. Yang United Kingdom	26	1.9k 0.5×	1.3k 0.4×	363 0.5×	130 0.4×	77 0.5×	89	2.2k
Mario Damiano Toro Italy	27	1.6k 0.4×	1.1k 0.4×	388 0.6×	115 0.3×	140 0.9×	148	2.1k
Samantha Fraser‐Bell Australia	31	3.6k 0.9×	2.9k 0.9×	307 0.5×	340 1.0×	65 0.4×	103	3.8k

Countries citing papers authored by Tsontcho Ianchulev

Since Specialization

Citations

This map shows the geographic impact of Tsontcho Ianchulev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsontcho Ianchulev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsontcho Ianchulev more than expected).

Fields of papers citing papers by Tsontcho Ianchulev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsontcho Ianchulev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsontcho Ianchulev. The network helps show where Tsontcho Ianchulev may publish in the future.

Co-authorship network of co-authors of Tsontcho Ianchulev

This figure shows the co-authorship network connecting the top 25 collaborators of Tsontcho Ianchulev. A scholar is included among the top collaborators of Tsontcho Ianchulev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsontcho Ianchulev. Tsontcho Ianchulev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ianchulev, Tsontcho, et al.. (2025). Autonomous Screening for Diabetic Macular Edema Using Deep Learning Processing of Retinal Images. Ophthalmology Science. 5(4). 100722–100722. 2 indexed citations

Ianchulev, Tsontcho, et al.. (2025). Micro-interventional pre-treatment for nucleus disassembly in the setting of non-cavitating sonic lensectomy: real-world evidence study in 512 cases. BMC Ophthalmology. 25(1). 362–362.

Beelen, Maarten, et al.. (2024). Microinterventional system for robot-assisted gonioscopic surgery– technical feasibility and preclinical evaluation in synthetic eye models. BMC Ophthalmology. 24(1). 324–324. 1 indexed citations

Ianchulev, Tsontcho, et al.. (2024). First in-human clinical performance of a new non-cavitating handheld lensectomy system in 665 consecutive cataract surgeries. Journal of Cataract & Refractive Surgery. 50(7). 693–697. 3 indexed citations

Radcliffe, Nathan M., et al.. (2024). Surgical Outcomes, Ocular Safety and Tolerability of Bio-Interventional Cyclodialysis with Allograft Scleral Reinforcement: Clinical Experience of More than 240 Cases. Journal of Clinical Medicine. 13(16). 4593–4593. 1 indexed citations

Ianchulev, Tsontcho, et al.. (2023). Biotissue stent for supraciliary outflow in open-angle glaucoma patients: surgical procedure and first clinical results of an aqueous drainage biostent. British Journal of Ophthalmology. 108(2). 217–222. 9 indexed citations

Chayet, Arturo, et al.. (2023). Pupil Dilation Evaluation of Two Mydriatic Dosing Profiles Delivered By the Optejet ^®. Therapeutic Delivery. 14(2). 93–103.

Ianchulev, Tsontcho, et al.. (2022). Predicting the future development of diabetic retinopathy using a deep learning algorithm for the analysis of non-invasive retinal imaging. BMJ Open Ophthalmology. 7(1). e001140–e001140. 18 indexed citations

Pasquale, Louis R., et al.. (2018). Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose. Clinical ophthalmology. Volume 12. 2451–2457. 7 indexed citations

10.

Ianchulev, Tsontcho, et al.. (2016). Office-Based Cataract Surgery. Ophthalmology. 123(4). 723–728. 73 indexed citations

11.

Grisanti, Swaantje, Salvatore Grisanti, H. Höh, et al.. (2015). Supraciliary Micro-stent Implantation for Open-Angle Glaucoma Failing Topical Therapy: 1-Year Results of a Multicenter Study. American Journal of Ophthalmology. 159(6). 1075–1081.e1. 82 indexed citations

12.

Craven, E. Randy, et al.. (2014). Standalone CyPass Micro-Stent implantation in patients refractory to topical glaucoma therapy: 1 year results. Investigative Ophthalmology & Visual Science. 55(13). 822–822. 1 indexed citations

13.

Vold, Steven D., Iqbal Ike K. Ahmed, Alfonso Antón, et al.. (2014). Initial Clinical Experience With the CyPass Micro-Stent. Journal of Glaucoma. 25(1). 106–112. 72 indexed citations

14.

Ianchulev, Tsontcho, et al.. (2013). Intraoperative Refractive Biometry for Predicting Intraocular Lens Power Calculation after Prior Myopic Refractive Surgery. Ophthalmology. 121(1). 56–60. 98 indexed citations

15.

Sadda, Srinivas R., Glenn Stoller, David S. Boyer, et al.. (2010). ANATOMICAL BENEFIT FROM RANIBIZUMAB TREATMENT OF PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE 2-YEAR ANCHOR STUDY. Retina. 30(9). 1390–1399. 25 indexed citations

16.

Brown, David M., Mark Michels, Peter K. Kaiser, et al.. (2008). Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study. Ophthalmology. 116(1). 57–65.e5. 1055 indexed citations breakdown →

17.

Regillo, Carl D., David M. Brown, Prema Abraham, et al.. (2008). Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1. American Journal of Ophthalmology. 145(2). 239–248.e5. 693 indexed citations breakdown →

18.

Francis, Brian A., et al.. (2005). Selective Laser Trabeculoplasty as a Replacement for Medical Therapy in Open-Angle Glaucoma. American Journal of Ophthalmology. 140(3). 524–525. 61 indexed citations

19.

Ianchulev, Tsontcho, James Salz, Kenneth J. Hoffer, et al.. (2005). Intraoperative optical refractive biometry for intraocular lens power estimation without axial length and keratometry measurements. Journal of Cataract & Refractive Surgery. 31(8). 1530–1536. 59 indexed citations

20.

Ambati, Jayakrishna, Balamurali K. Ambati, Sonia H. Yoo, Tsontcho Ianchulev, & Anthony P. Adamis. (2003). Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies. Survey of Ophthalmology. 48(3). 257–293. 748 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact